Healthcare

Avantor® Announces CEO Transition

Board initiates search process to identify next CEO RADNOR, Pa., April 25, 2025 /PRNewswire/ -- Avantor, Inc., a leading global…

8 months ago

Avantor® Reports First Quarter 2025 Results

Net sales of $1.58 billion, decrease of 6%; organic decline of 2%Net income of $64.5 million; Adjusted EBITDA of $269.5…

8 months ago

Avantor® Reports First Quarter 2025 Results

Net sales of $1.58 billion, decrease of 6%; organic decline of 2%Net income of $64.5 million; Adjusted EBITDA of $269.5…

8 months ago

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025

Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection,…

8 months ago

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025

Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection,…

8 months ago

Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025

CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug…

8 months ago

Press release: Transparency Notification from Shareholders

Transparency Notification from Shareholders Ghent, Belgium – 25 April 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or…

8 months ago

Somatic Health and Kinetisense to Commence a Groundbreaking Clinical Study with Rothman Orthopaedics

NEW YORK, April 24, 2025 /PRNewswire/ -- Somatic Health and Kinetisense are launching a cutting edge clinical study in partnership with…

8 months ago

A Success Story – DelveInsight’s Strategic Support to a Biopharma Leader in NSCLC Epidemiology Forecasting up to 2034, Segmented by Biomarker Types

In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company specializing in non-small…

8 months ago